We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Healthy and COPD Participants to Evaluate the Efficacy and Safety of Inhaled TV46017

- Chronic Obstructive Pulmonary Disease (COPD)
- Terminated

Study Title: Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017

Teva Identifier: TV46017-COPD-10046

ClinicalTrials.gov Identifier: NCT02315131

Study Status: Terminated

Trial Condition(s): Chronic Obstructive Pulmonary Disease (COPD)

Interventions: Drug: TV46017 | Drug: Placebo

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 20 Years to 75 Years

Trial Duration: 03/01/2015 - 08/01/2015

Phase: Phase 1

Study Type

Interventional